Eli Lilly
Venture capital · Indianapolis, Indiana, United States
Portfolio collected from the firm’s website, last checked Jun 28, 2026.Raises and exits come from each company’s own SEC and company records.
5Deep-tech portfolio3 active
2Portfolio exitsAcquired or listed
0Raises, 12 monthsLatest: Sionna Therapeutics
13Co-investorsShare a portfolio company
Portfolio · 5 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Gate Bioscience | Biotech | Active | — | — |
| Lyric Therapeutics | Biotech | Active | — | — |
| Versanis Bio | Biotech | Active | — | — |
| Merus | Biotech | Acquired | — | — |
| Sionna Therapeutics | Biotech | Public | — | — |
Peer ranks
Portfolio size#81
Portfolio exits#103
Raises, 12 months#88
Co-investors#144
Co-investors
- Lilly VenturesVenture capital3 shared
- Andreessen HorowitzVenture capital1 shared
- ARCH VentureVenture capital1 shared
- Atlas VentureVenture capital1 shared
- ForbionVenture capital1 shared
- GVVenture capital1 shared
- IncyteVenture capital1 shared
- MedicxiVenture capital1 shared
- OrbiMedVenture capital1 shared
- RA CapitalVenture capital1 shared
Sectors
- Biotech5
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.